PrulifloxacinIt is a thiazeto-quinoline derivative and is a lipophilic prodrug of ulifloxacin, orally effective antibacterial agent.
In the treatment of urinary tract (acute uncomplicated and complicated) and respiratory tract infections AECB.
600mg as a single dose in the treatment of acute uncomplicated lower UTIs, and as a once-daily 600mg dosage for a maximum of 10 days in the treatment of complicated lower UTIs.
Hypersensitivity. Pregnancy and lactation. Children or adolescents below 18 yr with uncomplicated skeletal development. History of tendon diseases related to administration of quinolones.
Blood dyscrasias; CNS disorders; Gastrointestinal disorders; Urticaria (occasional).
|Brand Name||Manufactured by|
|PRUDILA||CADILA PHARMACEUTICALS LTD.|
|PURIBACT||INVISION MEDI SCIENCES|
|RULING||GLOBUS REMEDIES LTD.|
|RULIZO||Sun Pharmaceutical Industries Ltd.|
|SUPERQUIN||PIRAMAL HEALTH LTD.|